Clinical trial
Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in…
NCT00053547 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00053547 |
|---|---|
| Title | Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis |
| Official title | Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism, End Stage Renal Disease |
| Intervention type | Drug |
| Interventions | paricalcitol injection |
| Enrollment | 28 |
| Start date | Jan 1, 2002 |
| First posted | Feb 3, 2003 |
| Last update posted | Aug 2, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: